BriMindInvest Logo

Welltower Inc. (WELL) Stock Analysis

Real EstateREIT - Healthcare Facilities
$211.45as of 2026-06-22

BriMind AI Score

Proprietary
52
Neutral
Price CAGR
14.9%
1Y Return
+36.6%
Analyst Upside
+13.9%
Rev Growth
38.3%

Score based on historical price CAGR, revenue growth, analyst upside, and valuation factors. Updated daily.

BriMind 1-Year Price Target

$238.05+12.6% potential
Bear Case
$148.15
Bull Case
$317.87
Model Confidence90%

BriMind AI combines DCF, momentum, and analyst consensus to project a 12-month price target.

WELL Revenue & Profitability Breakdown

This chart shows how WELL's revenue flows through to profit. Each row deducts a layer of costs: first the direct cost of making products/services (Cost of Revenue), then operating expenses like marketing and R&D, then taxes. What remains at the bottom is net income — the actual profit shareholders own. High gross and net margins indicate a business with strong pricing power and efficiency.

Revenue
$11.77B
Cost of Revenue
-$7.08B
Gross Profit
$4.69B39.9% margin
Operating Expenses
-$2.57B
Operating Income
$2.12B18.0% margin
Tax & Other
-$715.1M
Net Income
$1.41B12.0% margin
Gross Margin
39.9%
Operating Margin
18.0%
Net Margin
12.0%
EBITDA Margin
36.9%

Key Financial Metrics

A snapshot of the company's valuation, growth, profitability, and financial health. Key things to look at: P/E ratio measures how much you pay for $1 of earnings (lower = cheaper, but fast-growing companies command higher P/E); Free Cash Flow is the cash left after running the business — companies with strong FCF can buy back shares, pay dividends, or invest; Debt/Equity shows how leveraged the company is (high debt can be risky); Return on Equity tells you how efficiently the company generates profit from shareholders' money.

Market Cap
$145.88B
Enterprise Value
$115.14B
P/E (Trailing)
99.83
P/E (Forward)
61.50
EV / EBITDA
36.51
Price / Sales
11.81
Price / Book
2.97
Revenue
$11.77B
Revenue Growth
38.3%
Earnings Growth
157.9%
EBITDA
$3.15B
Gross Margin
39.9%
Operating Margin
18.0%
Net Margin
12.0%
Return on Equity
3.7%
Return on Assets
0.7%
Free Cash Flow
$2.60B
Total Cash
$3.50B
Total Debt
$17.01B
Debt / Equity
44.49
Current Ratio
1.65
Quick Ratio
1.24
Beta
0.78
Dividend Yield
1.4%
Payout Ratio
139.6%
Book Value / Share
$60.49

Wall Street Analyst Consensus

Professional analysts at investment banks set 12-month price targets after researching the company's earnings, competitive position, and industry trends. Strong Buy / Buy means the majority expect meaningful upside. Hold means analysts see fair value near the current price — not a sell signal, but limited near-term upside expected. The mean target is the average of all analyst price targets; the range shows where the most optimistic and most cautious analysts stand.

Consensus RatingBuy(20 analysts)
SellStrong Buy
Low Target$145.00-31.4%
Mean Target$235.48+11.4% upside
High Target$240.00+13.5%

Intrinsic Value Estimates for WELL

Intrinsic value is what a stock is truly worth based on the company's fundamentals — independent of what the market currently prices it at. We use multiple models because no single formula is perfect: each captures different aspects of a business. If multiple models agree the stock is undervalued, that convergence is a stronger signal. A stock trading well below its intrinsic value may be a bargain; one far above may carry more risk.

DCF Model (10yr)
$83.50
-60.5% vs current
Discounts 10 years of projected free cash flow back to today's dollars (5% growth, 10% discount rate). Best for companies generating consistent cash.
Fair Value Range
$83.50 – $83.50
Average Estimate
$83.50
Potential Downside
-60.5%

⚠️ Intrinsic value estimates use simplified models (Graham, DCF, P/E) and conservative assumptions. They should be used as one input among many — not as sole buy/sell guidance. For advanced analysis, see the full platform.

Compare WELL with Peers

WELL vs VTRWelltower vs Ventas — Which Healthcare REIT Wins?
CTRE vs WELLCareTrust REIT vs Welltower — Small vs Large Healthcare

Unlock the Full WELL Analysis

Interactive price charts, real-time AI signals, advanced DCF models, portfolio tracking, earnings analysis, and side-by-side peer comparisons. Start your 21-day free trial — no credit card required.

Start Free TrialBrowse All Stocks
← Back to Home · Browse All Stock Analysis